Cosentyx is a medication used to treat various inflammatory conditions, such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. To understand how Cosentyx users may be affected, let's analyze the provided sources.

According to the first source, Drug Patent Watch, Cosentyx is classified as a biologic drug. Biologics are complex medications derived from living organisms and are typically more expensive than traditional drugs. The patent for Cosentyx is set to expire in 2024, which means that after this date, generic versions of the drug may become available. This could potentially lead to lower costs for Cosentyx users as generic drugs are usually more affordable.

The second source, a study published in the National Center for Biotechnology Information, provides insights into the effectiveness and safety of Cosentyx. The study concludes that Cosentyx is an effective treatment option for psoriasis, psoriatic arthritis, and ankylosing spondylitis, with a favorable safety profile. It highlights the importance of regular monitoring and communication between patients and healthcare providers to ensure optimal treatment outcomes.

The third source is the official website of Cosentyx. It provides information about the drug, its indications, and the support services available for patients. The website emphasizes the importance of regular communication with healthcare providers and offers resources such as financial assistance programs and a patient support app.

Based on these sources, it can be concluded that Cosentyx users may be affected in the following ways:

1. Cost: The expiration of the patent in 2024 may lead to the availability of generic versions of Cosentyx, potentially reducing the cost of the medication for users [1].

2. Effectiveness and Safety: Cosentyx has been shown to be effective and safe in treating psoriasis, psoriatic arthritis, and ankylosing spondylitis [2]. However, it is important for users to regularly communicate with their healthcare providers to ensure optimal treatment outcomes.

3. Support Services: Cosentyx offers support services for patients, including financial assistance programs and a patient support app [3]. These resources can help users access the medication and manage their condition effectively.

In summary, Cosentyx users may experience potential cost savings with the availability of generic versions after the patent expiration. The medication has been found to be effective and safe, but regular communication with healthcare providers is crucial. Additionally, support services provided by Cosentyx can assist users in managing their condition.

Sources:
[1] Drug Patent Watch - https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] National Center for Biotechnology Information - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883240/
[3] Cosentyx Official Website - https://www.cosentyx.com/